We are identifying and utilizing new ways to address cancer at its core. Combining our expertise in molecular cancer biology, epigenetics, cancer stem cell biology, with preclinical and clinical drug development, we are creating novel therapeutics to unlock new pathways to treat advanced cancers.follow the science
Innovators in Our Field
Tachyon operates with a dedicated internal core development team and a broad virtual external network of expertise to achieve one goal – advance our program with speed and innovation, without compromising the quality or integrity of our science.Meet the tachyon team
Tachyon completed seed funding and established fully operational organization.
Tachyon founded by scientific inventors to advance KDM4 program for clinical development.